Environmental influences on systemic lupus erythematosus expression

Rheumatic Disease Clinics of North America

Volumn 40, Issue 3, 2014, Pages 401-412

  Kamen, Diane L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Environment; Etiology; Risk factors; Systemic lupus erythematosus; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ASBESTOS; COSMETIC; DIOXIN; EPSTEIN BARR VIRUS ANTIGEN 1; FURAN DERIVATIVE; HYDRALAZINE; INDUSTRIAL CHEMICAL; MERCURY; METAL; ORGANOCHLORINE PESTICIDE; ORGANOHALOGEN DERIVATIVE; PESTICIDE; POLYCHLORINATED BIPHENYL; PROCAINAMIDE; RO ANTIBODY; SILICON DIOXIDE; SM ANTIBODY; SOLVENT; VITAMIN D;

AIR POLLUTION; ALFALFA; DIETARY INTAKE; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIGENETICS; EPSTEIN BARR VIRUS INFECTION; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LUPUS LIKE SYNDROME; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW; SILICOSIS; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; ULTRAVIOLET RADIATION; VITAMIN D DEFICIENCY; ADVERSE EFFECTS; CASE CONTROL STUDY; CLASSIFICATION; DIET; LUPUS ERYTHEMATOSUS, SYSTEMIC; RISK FACTOR; TIME;

CASE-CONTROL STUDIES; DIET SURVEYS; ENVIRONMENTAL EXPOSURE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RISK FACTORS; TIME;

EID: 84904286053     PISSN: 0889857X     EISSN: 15583163     Source Type: Journal    
DOI: 10.1016/j.rdc.2014.05.003     Document Type: Review

References (63)

1. Somers E.C., Marder W., Cagnoli P., et al. Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan lupus epidemiology and surveillance program. Arthritis Rheum 2014, 66:369-378.
2. Helmick C.G., Felson D.T., Lawrence R.C., et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008, 58:15-25.
3. Pons-Estel G.J., Alarcon G.S. Lupus in Hispanics: a matter of serious concern. Cleve Clin J Med 2012, 79:824-834.
4. Lim S.S., Bayakly A.R., Helmick C.G., et al. The incidence and prevalence of systemic lupus erythematosus, 2002-2004: the Georgia lupus registry. Arthritis Rheum 2014, 66:357-368.
5. Arbuckle M.R., McClain M.T., Rubertone M.V., et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. NEngl J Med 2003, 349:1526-1533.
6. McClain M.T., Heinlen L.D., Dennis G.J., et al. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 2005, 11:85-89.
7. Alarcon-Segovia D., Alarcon-Riquelme M.E., Cardiel M.H., et al. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum 2005, 52:1138-1147.
8. Kamen D.L., Barron M., Parker T.M., et al. Autoantibody prevalence and lupus characteristics in a unique African American population. Arthritis Rheum 2008, 58:1237-1247.
9. Bruner B.F., Guthridge J.M., Lu R., et al. Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members. Arthritis Rheum 2012, 64:3677-3686.
10. Cooper G.S., Miller F.W., Pandey J.P. The role of genetic factors in autoimmune disease: implications for environmental research. Environ Health Perspect 1999, 107(Suppl 5):693-700.
11. Wild C.P. Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 2005, 14:1847-1850.
12. Webb R., Kelly J.A., Somers E.C., et al. Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients. Ann Rheum Dis 2011, 70:151-156.
13. Rullo O.J., Tsao B.P. Recent insights into the genetic basis of systemic lupus erythematosus. Ann Rheum Dis 2013, 72(Suppl 2):ii56-ii61.
14. Fraga M.F., Ballestar E., Paz M.F., et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 2005, 102:10604-10609.
15. Absher D.M., Li X., Waite L.L., et al. Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet 2013, 9:e1003678.
16. Hedrich C.M., Tsokos G.C. Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases. Trends Mol Med 2011, 17:714-724.
17. Hughes T., Sawalha A.H. The role of epigenetic variation in the pathogenesis of systemic lupus erythematosus. Arthritis Res Ther 2011, 13:245.
18. Klack K., Bonfa E., Borba Neto E.F. Diet and nutritional aspects in systemic lupus erythematosus. Rev Bras Reumatol 2012, 52:384-408.
19. Petri M. Diet and systemic lupus erythematosus: from mouse and monkey to woman?. Lupus 2001, 10:775-777.
20. Bengtsson A.A., Rylander L., Hagmar L., et al. Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden. Rheumatology 2002, 41:563-571.
21. Strickland F.M., Hewagama A., Wu A., et al. Diet influences expression of autoimmune-associated genes and disease severity by epigenetic mechanisms in a transgenic mouse model of lupus. Arthritis Rheum 2013, 65:1872-1881.
22. Costenbader K.H., Feskanich D., Holmes M., et al. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 2008, 67:530-535.
23. Hiraki L.T., Munger K.L., Costenbader K.H., et al. Dietary intake of vitamin D during adolescence and risk of adult-onset systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012, 64:1829-1836.
24. Costenbader K.H., Kang J.H., Karlson E.W. Antioxidant intake and risks of rheumatoid arthritis and systemic lupus erythematosus in women. Am J Epidemiol 2010, 172:205-216.
25. Miller F.W., Alfredsson L., Costenbader K.H., et al. Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. JAutoimmun 2012, 39:259-271.
26. Parks C.G., Cooper G.S., Nylander-French L.A., et al. Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: a population-based, case-control study in the southeastern United States. Arthritis Rheum 2002, 46:1840-1850.
27. Finckh A., Cooper G.S., Chibnik L.B., et al. Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women. Arthritis Rheum 2006, 54:3648-3654.
28. Cooper G.S., Wither J., Bernatsky S., et al. Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents. Rheumatology 2010, 49:2172-2180.
29. Makol A., Reilly M.J., Rosenman K.D. Prevalence of connective tissue disease in silicosis (1985-2006) - a report from the state of Michigan surveillance system for silicosis. Am J Ind Med 2011, 54:255-262.
30. Conrad K., Mehlhorn J., Luthke K., et al. Systemic lupus erythematosus after heavy exposure to quartz dust in uranium mines: clinical and serological characteristics. Lupus 1996, 5:62-69.
31. Brown L.M., Gridley G., Olsen J.H., et al. Cancer risk and mortality patterns among silicotic men in Sweden and Denmark. JOccup Environ Med 1997, 39:633-638.
32. Hogan S.L., Satterly K.K., Dooley M.A., et al. Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis. JAm Soc Nephrol 2001, 12:134-142.
33. Costenbader K.H., Kim D.J., Peerzada J., et al. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum 2004, 50:849-857.
34. Ekblom-Kullberg S., Kautiainen H., Alha P., et al. Smoking and the risk of systemic lupus erythematosus. Clin Rheumatol 2013, 32(8):1219-1222.
35. Bourre-Tessier J., Peschken C.A., Bernatsky S., et al. Smoking is associated with cutaneous manifestations in systemic lupus erythematosus. Arthritis Care Res 2013, 65(8):1275-1280.
36. Kiyohara C., Washio M., Horiuchi T., et al. Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of cigarette smoking and systemic lupus erythematosus in a Japanese population. Scand J Rheumatol 2012, 41:103-109.
37. Caza T., Oaks Z., Perl A. Interplay of infections, autoimmunity, and immunosuppression in systemic lupus erythematosus. Int Rev Immunol 2014, [Epub ahead of print].
38. Parks C.G., Cooper G.S., Hudson L.L., et al. Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis Rheum 2005, 52:1148-1159.
39. James J.A., Neas B.R., Moser K.L., et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum 2001, 44:1122-1126.
40. McClain M.T., Poole B.D., Bruner B.F., et al. An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus. Arthritis Rheum 2006, 54:360-368.
41. Yu S.F., Wu H.C., Tsai W.C., et al. Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in Taiwan. Med Microbiol Immunol 2005, 194:115-120.
42. Hanlon P., Avenell A., Aucott L., et al. Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus. Arthritis Res Ther 2014, 16:R3.
43. Vaughn S.E., Kottyan L.C., Munroe M.E., et al. Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways. JLeukoc Biol 2012, 92(3):577-591.
44. Kamen D.L., Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. JMol Med 2010, 88:441-450.
45. Ben-Zvi I., Aranow C., Mackay M., et al. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One 2010, 5:e9193.
46. Amital H., Szekanecz Z., Szucs G., et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?. Ann Rheum Dis 2010, 69:1155-1157.
47. Mok C.C., Birmingham D.J., Leung H.W., et al. Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology 2011, 51(4):644-652.
48. Ritterhouse L.L., Crowe S.R., Niewold T.B., et al. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis 2011, 70:1569-1574.
49. Lertratanakul A., Wu P., Dyer A., et al. 25-Hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort. Arthritis Care Res (Hoboken) 2014, [Epub ahead of print].
50. Kamen D.L., Cooper G.S., Bouali H., et al. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006, 5:114-117.
51. Ritterhouse L.L., Lu R., Shah H.B., et al. Vitamin D deficiency in a multiethnic healthy control cohort and altered immune response in vitamin D deficient European-American healthy controls. PLoS One 2014, 9:e94500.
52. Nyland J.F., Fillion M., Barbosa F., et al. Biomarkers of methyl mercury exposure immunotoxicity among fish consumers in Amazonian Brazil. Environ Health Perspect 2011, 119:1733-1738.
53. Gold L.S., Ward M.H., Dosemeci M., et al. Systemic autoimmune disease mortality and occupational exposures. Arthritis Rheum 2007, 56:3189-3201.
54. Wang F., Roberts S.M., Butfiloski E.J., et al. Acceleration of autoimmunity by organochlorine pesticides: a comparison of splenic B-cell effects of chlordecone and estradiol in (NZBxNZW)F1 mice. Toxicol Sci 2007, 99:141-152.
55. Cooper G.S., Parks C.G., Treadwell E.L., et al. Occupational risk factors for the development of systemic lupus erythematosus. JRheumatol 2004, 31:1928-1933.
56. Parks C.G., Walitt B.T., Pettinger M., et al. Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the Women's Health Initiative Observational Study. Arthritis Care Res 2011, 63:184-194.
57. DeWitt J.C., Peden-Adams M.M., Keller J.M., et al. Immunotoxicity of perfluorinated compounds: recent developments. Toxicol Pathol 2012, 40:300-311.
58. Robinson C.F., Petersen M., Palu S. Mortality patterns among electrical workers employed in the U.S. construction industry, 1982-1987. Am J Ind Med 1999, 36:630-637.
59. Tsai P.C., Ko Y.C., Huang W., et al. Increased liver and lupus mortalities in 24-year follow-up of the Taiwanese people highly exposed to polychlorinated biphenyls and dibenzofurans. Sci Total Environ 2007, 374:216-222.
60. Kamen D.L., Peden-Adams M.M., Vena J.E., et al. Seafood consumption and persistent organic pollutants as triggers of autoimmunity among Gullah African Americans. Arthritis Res Ther 2012, 14:A19.
61. Barragan-Martinez C., Speck-Hernandez C.A., Montoya-Ortiz G., et al. Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis. PLoS One 2012, 7:e51506.
62. Smith M.T., Zhang L., McHale C.M., et al. Benzene, the exposome and future investigations of leukemia etiology. Chem Biol Interact 2011, 192:155-159.
63. Cornelis M.C., Agrawal A., Cole J.W., et al. The Gene, Environment Association Studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions. Genet Epidemiol 2010, 34:364-372.